• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

TargetRx to Deliver Plenary Address at Pharmaceutical Executive Marketing & Sales Summit

Posted on: Friday, 2 November 2007, 09:00 CDT

TargetRx today announced that the company's President and CEO Mike Luby will deliver a plenary address at the upcoming Pharmaceutical Executive Marketing & Sales Summit to be held November 4-6, 2007 in Philadelphia.

This second annual conference from Pharmaceutical Executive will address the most critical issues and changes impacting pharmaceutical and biopharmaceutical marketing and sales executives. This year's program features presentations from top executives at Lilly USA, GlaxoSmithKline and Abbott, among others.

Pharmaceutical Executive's Marketing & Sales Summit

November 4-6, 2007, Pennsylvania Convention Center, Philadelphia, Pa.

Opening Address: "How Pharmaceutical Companies Can Measure, Manage and Improve Sales and Marketing Effectiveness"

Tuesday, November 6, 2007, 8:05-8:45 a.m.

Following the opening remarks from Patrick Clinton, Editor-in-Chief of Pharmaceutical Executive, Luby will present TargetRx's latest insights into sales and marketing quality and recent acknowledgements by pharmaceutical companies of the importance of improving the effectiveness and efficiency of sales and marketing in the current environment. TargetRx has ground-breaking insights based on more than six years of research into the methods by which pharmaceutical companies can measure, manage, and improve the performance of sales and marketing.

In his presentation, Luby will review the factors that are critical to successful execution, highlight sales and marketing industry trends and forecast opportunities that will play out in the near future. While the industry knows it needs to improve the efficiency of its sales and marketing efforts - with many pharmaceutical companies downsizing field forces, reorganizing existing ones and piloting new approaches - no one seems to have cracked the code on sales and marketing effectiveness. This opening address will provide insight into several sales and marketing strategies and how pharmaceutical companies are executing to make sales and marketing more effective. Luby's presentation will be followed by the keynote address from Martin Soeters, President of Novo Nordisk.

For more information or to register for this event, visit: http://www.pharmexecsummit.com/pharmexecsummit/v42/index.cvn?id=10000

About TargetRx

TargetRx helps pharmaceutical companies create competitive advantage and shareholder value through unparalleled insight into the drivers of physician prescribing behavior. TargetRx employs a patented approach to capturing physician attitudes and utilizing proprietary predictive modeling to translate the findings into highly actionable insights for its clients. These insights provide companies with the ability to "measure, manage, and improve" their sales and marketing efforts. By capturing information from physicians regarding their interests and advocating for physicians with pharmaceutical companies, TargetRx has created a unique value proposition with benefits for patients, physicians, and pharmaceutical companies. TargetRx works with the majority of the top 30 pharmaceutical companies in the U.S. For further information, visit http://www.targetrx.com/.

Source: Business Wire

More News in this Category